Bioceltix SA shareholders have approved the share issue. The company plans to raise approximately PLN 45 million for the construction of a new stem cell facility.

Bioceltix, a publicly traded biotechnology company with a veterinary profile, received shareholder support for an issue of up to 457,000 shares during its Extraordinary General Meeting. The company plans to raise approximately PLN 45 million, which will allow it to complete the construction of a large-scale pharmaceutical production facility and secure its financial position for […]